Avior Wealth Management LLC Makes New Investment in Colgate-Palmolive Company $CL

Avior Wealth Management LLC acquired a new position in Colgate-Palmolive Company (NYSE:CL) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 14,362 shares of the company’s stock, valued at approximately $1,135,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CL. Copia Wealth Management purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $29,000. Vermillion & White Wealth Management Group LLC grew its position in Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after acquiring an additional 155 shares in the last quarter. Cloud Capital Management LLC purchased a new position in Colgate-Palmolive in the third quarter worth $30,000. Global Wealth Strategies & Associates increased its stake in Colgate-Palmolive by 300.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after acquiring an additional 300 shares during the last quarter. Finally, Kelleher Financial Advisors purchased a new stake in Colgate-Palmolive during the third quarter valued at about $35,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CL has been the subject of a number of research reports. Wall Street Zen upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Saturday. Piper Sandler boosted their target price on Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. Barclays upped their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Finally, Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.75.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $85.14 on Friday. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The firm’s fifty day simple moving average is $91.01 and its 200 day simple moving average is $83.36. The stock has a market cap of $68.62 billion, a P/E ratio of 32.49, a price-to-earnings-growth ratio of 3.81 and a beta of 0.28. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.91 EPS. As a group, research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.5%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 79.39%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the transaction, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider John Hazlin sold 20,989 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This represents a 54.33% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 184,683 shares of company stock valued at $17,486,693. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.